Zinc in PDB 6h18: Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Enzymatic activity of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
All present enzymatic activity of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase:
3.1.1.13;
3.1.1.3;
Protein crystallography data
The structure of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase, PDB code: 6h18
was solved by
C.Touvrey,
X.Brazzolotto,
F.Nachon,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.43 /
1.85
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.702,
98.055,
110.888,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.8 /
23.6
|
Zinc Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
11;
Binding sites:
The binding sites of Zinc atom in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
(pdb code 6h18). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 11 binding sites of Zinc where determined in the
Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase, PDB code: 6h18:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Zinc binding site 1 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 1 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn601
b:32.0
occ:1.00
|
O
|
A:HOH731
|
2.1
|
28.2
|
1.0
|
O
|
A:HOH867
|
2.1
|
40.9
|
1.0
|
O
|
A:ACT614
|
2.2
|
34.5
|
1.0
|
NE2
|
A:HIS48
|
2.2
|
32.0
|
1.0
|
OXT
|
A:ACT614
|
2.3
|
45.3
|
1.0
|
O
|
A:HOH714
|
2.4
|
36.8
|
1.0
|
C
|
A:ACT614
|
2.5
|
38.9
|
1.0
|
CD2
|
A:HIS48
|
3.1
|
26.5
|
1.0
|
CE1
|
A:HIS48
|
3.2
|
33.1
|
1.0
|
OH
|
A:TYR82
|
3.8
|
37.0
|
1.0
|
CH3
|
A:ACT614
|
4.1
|
38.1
|
1.0
|
OD2
|
A:ASP79
|
4.2
|
22.9
|
1.0
|
ND1
|
A:HIS48
|
4.3
|
32.4
|
1.0
|
CG
|
A:HIS48
|
4.3
|
27.4
|
1.0
|
OD1
|
A:ASP79
|
4.3
|
29.4
|
1.0
|
CB
|
A:PRO34
|
4.4
|
24.8
|
1.0
|
O
|
A:HOH738
|
4.6
|
28.4
|
1.0
|
CD
|
A:PRO38
|
4.6
|
31.2
|
1.0
|
CG
|
A:PRO34
|
4.7
|
26.9
|
1.0
|
CZ
|
A:TYR82
|
4.7
|
32.5
|
1.0
|
CG
|
A:ASP79
|
4.7
|
29.0
|
1.0
|
CE2
|
A:TYR82
|
4.8
|
29.9
|
1.0
|
CG
|
A:PRO38
|
4.8
|
29.6
|
1.0
|
|
Zinc binding site 2 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 2 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn602
b:32.1
occ:1.00
|
OXT
|
A:ACT613
|
1.9
|
33.0
|
1.0
|
NE2
|
A:HIS168
|
2.1
|
30.3
|
1.0
|
C
|
A:ACT613
|
2.6
|
36.7
|
1.0
|
O
|
A:ACT613
|
2.8
|
33.9
|
1.0
|
CE1
|
A:HIS168
|
3.0
|
30.6
|
1.0
|
CD2
|
A:HIS168
|
3.1
|
25.6
|
1.0
|
CH3
|
A:ACT613
|
4.1
|
40.4
|
1.0
|
ND1
|
A:HIS168
|
4.1
|
27.9
|
1.0
|
CD2
|
A:TYR208
|
4.2
|
35.7
|
1.0
|
CG
|
A:HIS168
|
4.2
|
26.9
|
1.0
|
O
|
A:TYR208
|
4.5
|
25.0
|
1.0
|
CE2
|
A:TYR208
|
4.8
|
35.2
|
1.0
|
|
Zinc binding site 3 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 3 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn603
b:32.1
occ:1.00
|
OD1
|
A:ASP77
|
2.0
|
30.4
|
1.0
|
OE2
|
A:GLU78
|
2.0
|
33.3
|
1.0
|
CD
|
A:GLU78
|
2.7
|
34.1
|
1.0
|
CG
|
A:ASP77
|
2.7
|
27.4
|
1.0
|
OD2
|
A:ASP77
|
2.8
|
26.5
|
1.0
|
OE1
|
A:GLU78
|
2.8
|
31.3
|
1.0
|
CG
|
A:GLU78
|
4.1
|
29.8
|
1.0
|
CB
|
A:ASP77
|
4.2
|
24.0
|
1.0
|
N
|
A:GLU78
|
4.5
|
31.1
|
1.0
|
CA
|
A:ASP77
|
4.8
|
27.4
|
1.0
|
|
Zinc binding site 4 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 4 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn604
b:67.0
occ:1.00
|
NE2
|
A:HIS115
|
2.3
|
48.4
|
1.0
|
O
|
A:ACT615
|
2.5
|
59.1
|
1.0
|
C
|
A:ACT615
|
3.1
|
50.9
|
1.0
|
OXT
|
A:ACT616
|
3.1
|
60.3
|
1.0
|
CE1
|
A:HIS115
|
3.1
|
51.2
|
1.0
|
OXT
|
A:ACT615
|
3.2
|
59.6
|
1.0
|
C
|
A:ACT616
|
3.2
|
59.9
|
1.0
|
CD2
|
A:HIS115
|
3.4
|
47.9
|
1.0
|
O
|
A:ACT616
|
3.6
|
60.2
|
1.0
|
CH3
|
A:ACT616
|
3.7
|
65.2
|
1.0
|
NH1
|
A:ARG63
|
3.8
|
56.7
|
1.0
|
ND1
|
A:HIS115
|
4.3
|
52.2
|
1.0
|
O
|
A:HOH806
|
4.4
|
44.8
|
1.0
|
CG
|
A:HIS115
|
4.4
|
45.1
|
1.0
|
CH3
|
A:ACT615
|
4.5
|
43.4
|
1.0
|
CD
|
A:ARG63
|
4.6
|
45.0
|
1.0
|
O
|
A:LYS61
|
4.7
|
38.9
|
1.0
|
CZ
|
A:ARG63
|
4.9
|
50.9
|
1.0
|
OG
|
A:SER113
|
5.0
|
41.1
|
1.0
|
|
Zinc binding site 5 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 5 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn605
b:63.8
occ:1.00
|
OD1
|
A:ASP457
|
2.1
|
45.4
|
1.0
|
NE2
|
A:HIS435
|
2.2
|
51.2
|
1.0
|
CE1
|
A:HIS420
|
2.3
|
60.7
|
1.0
|
NH2
|
A:ARG454
|
2.5
|
55.0
|
1.0
|
NH1
|
A:ARG454
|
2.8
|
65.2
|
1.0
|
CD2
|
A:HIS435
|
3.0
|
54.5
|
1.0
|
CG
|
A:ASP457
|
3.0
|
46.1
|
1.0
|
CZ
|
A:ARG454
|
3.0
|
62.7
|
1.0
|
ND1
|
A:HIS420
|
3.3
|
64.6
|
1.0
|
CE1
|
A:HIS435
|
3.3
|
51.5
|
1.0
|
OD2
|
A:ASP457
|
3.3
|
48.5
|
1.0
|
NE2
|
A:HIS420
|
3.3
|
61.2
|
1.0
|
OH
|
A:TYR441
|
3.5
|
45.8
|
1.0
|
CG
|
A:HIS435
|
4.2
|
55.8
|
1.0
|
ND1
|
A:HIS435
|
4.3
|
52.9
|
1.0
|
NE
|
A:ARG454
|
4.3
|
69.6
|
1.0
|
CB
|
A:ASP457
|
4.4
|
43.9
|
1.0
|
CG
|
A:HIS420
|
4.5
|
63.0
|
1.0
|
CD2
|
A:HIS420
|
4.5
|
63.0
|
1.0
|
CZ
|
A:TYR441
|
4.5
|
43.3
|
1.0
|
CE2
|
A:TYR441
|
4.7
|
37.8
|
1.0
|
CA
|
A:ASP457
|
4.8
|
41.1
|
1.0
|
N
|
A:ASP457
|
5.0
|
41.6
|
1.0
|
|
Zinc binding site 6 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 6 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn606
b:29.4
occ:1.00
|
OE1
|
A:GLU489
|
2.0
|
29.6
|
1.0
|
O
|
A:ACT612
|
2.0
|
35.1
|
1.0
|
NE2
|
A:HIS487
|
2.1
|
27.1
|
1.0
|
OXT
|
A:ACT612
|
2.4
|
33.5
|
1.0
|
C
|
A:ACT612
|
2.4
|
33.0
|
1.0
|
CD
|
A:GLU489
|
2.8
|
31.5
|
1.0
|
OE2
|
A:GLU489
|
2.9
|
34.0
|
1.0
|
CD2
|
A:HIS487
|
3.0
|
25.2
|
1.0
|
CE1
|
A:HIS487
|
3.1
|
25.4
|
1.0
|
CH3
|
A:ACT612
|
4.0
|
32.1
|
1.0
|
CG
|
A:GLU489
|
4.2
|
29.2
|
1.0
|
CG
|
A:HIS487
|
4.2
|
25.2
|
1.0
|
ND1
|
A:HIS487
|
4.2
|
26.6
|
1.0
|
CD
|
A:PRO490
|
4.4
|
29.1
|
1.0
|
CA
|
A:GLU489
|
4.5
|
24.1
|
1.0
|
CB
|
A:GLU489
|
4.6
|
23.9
|
1.0
|
|
Zinc binding site 7 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 7 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn607
b:72.3
occ:1.00
|
OD2
|
A:ASP97
|
2.4
|
55.9
|
1.0
|
OD1
|
A:ASP97
|
2.6
|
40.3
|
1.0
|
CG
|
A:ASP97
|
2.8
|
40.9
|
1.0
|
CB
|
A:ASP97
|
4.3
|
33.8
|
1.0
|
|
Zinc binding site 8 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 8 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 8 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn608
b:90.2
occ:1.00
|
ND1
|
A:HIS283
|
2.1
|
63.8
|
1.0
|
O
|
A:HOH855
|
2.3
|
57.5
|
1.0
|
O
|
A:ACT618
|
2.6
|
58.0
|
1.0
|
OXT
|
A:ACT618
|
2.8
|
74.8
|
1.0
|
CE1
|
A:HIS283
|
2.9
|
64.9
|
1.0
|
C
|
A:ACT618
|
3.0
|
67.1
|
1.0
|
CG
|
A:HIS283
|
3.3
|
57.8
|
1.0
|
CB
|
A:HIS283
|
3.8
|
53.1
|
1.0
|
NE2
|
A:HIS283
|
4.1
|
63.3
|
1.0
|
CA
|
A:HIS283
|
4.3
|
52.9
|
1.0
|
CD2
|
A:HIS283
|
4.3
|
56.4
|
1.0
|
CH3
|
A:ACT618
|
4.6
|
50.1
|
1.0
|
CD2
|
A:TYR279
|
4.9
|
71.6
|
1.0
|
CD1
|
A:ILE353
|
5.0
|
61.6
|
1.0
|
|
Zinc binding site 9 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 9 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 9 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn609
b:75.1
occ:1.00
|
OE1
|
A:GLU350
|
2.1
|
55.9
|
1.0
|
CD
|
A:GLU350
|
2.7
|
52.3
|
1.0
|
OE2
|
A:GLU350
|
2.8
|
67.9
|
1.0
|
O
|
A:HOH885
|
3.3
|
55.3
|
1.0
|
CG
|
A:GLU350
|
4.2
|
44.9
|
1.0
|
CG2
|
A:ILE353
|
4.4
|
44.1
|
1.0
|
CD2
|
A:TYR279
|
4.5
|
71.6
|
1.0
|
CE2
|
A:TYR279
|
4.6
|
73.2
|
1.0
|
CB
|
A:GLU350
|
4.7
|
37.4
|
1.0
|
CA
|
A:GLU350
|
4.7
|
35.2
|
1.0
|
|
Zinc binding site 10 out
of 11 in 6h18
Go back to
Zinc Binding Sites List in 6h18
Zinc binding site 10 out
of 11 in the Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 10 of Crystal Structure of Sarin Surrogate Nimp Inhibited Recombinant Human Bile Salt Activated Lipase within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn610
b:78.6
occ:1.00
|
CE1
|
A:HIS322
|
2.7
|
55.1
|
1.0
|
OD2
|
A:ASP434
|
2.9
|
77.4
|
1.0
|
OD1
|
A:ASP437
|
3.5
|
52.5
|
1.0
|
ND1
|
A:HIS322
|
3.5
|
56.3
|
1.0
|
NE2
|
A:HIS322
|
3.6
|
67.5
|
1.0
|
OD1
|
A:ASP434
|
3.7
|
77.2
|
1.0
|
CG
|
A:ASP434
|
3.7
|
76.7
|
1.0
|
O
|
A:ACT617
|
4.0
|
67.1
|
1.0
|
CB
|
A:ASP437
|
4.3
|
51.0
|
1.0
|
CG
|
A:ASP437
|
4.4
|
45.3
|
1.0
|
OD2
|
A:ASP320
|
4.4
|
39.5
|
1.0
|
CA
|
A:ASP437
|
4.6
|
41.1
|
1.0
|
ND2
|
A:ASN317
|
4.6
|
38.3
|
0.6
|
O
|
A:MET319
|
4.6
|
46.5
|
1.0
|
CG
|
A:HIS322
|
4.8
|
56.2
|
1.0
|
CD2
|
A:HIS322
|
4.8
|
63.5
|
1.0
|
C
|
A:ACT617
|
4.9
|
53.8
|
1.0
|
N
|
A:ASP437
|
4.9
|
55.8
|
1.0
|
CG2
|
A:ILE323
|
4.9
|
61.7
|
1.0
|
CA
|
A:ASP320
|
4.9
|
35.8
|
1.0
|
O
|
A:ASP320
|
4.9
|
35.3
|
1.0
|
OD1
|
A:ASN317
|
4.9
|
37.7
|
0.4
|
|
Reference:
C.Touvrey,
C.Courageux,
V.Guillon,
R.Terreux,
F.Nachon,
X.Brazzolotto.
X-Ray Structures of Human Bile-Salt Activated Lipase Conjugated to Nerve Agents Surrogates. Toxicology V. 411 15 2019.
ISSN: ISSN 1879-3185
PubMed: 30359675
DOI: 10.1016/J.TOX.2018.10.015
Page generated: Mon Oct 28 22:18:24 2024
|